Viewpoint News & Awards

Viewpoint Rings in New Year – 4th SBIR ($300,000) Awarded by NIH

January 7, 2016 (Coralville, IA) – Viewpoint is pleased to announce it has secured a fourth consecutive collaborative Small Business Innovation Research (SBIR) Grant ($300,000), awarded by the National Institutes of Health. The funding, which brings total funding awarded to the company in the last 24 months over $1.2M, provides support for exciting new product development that advances its novel image-guided therapy for metastatic melanoma toward early phase clinical trials. “It is exciting to see that our peers are recognizing the potential of our image-guided therapy approach,” states Frances Johnson MD, Chief Medical Officer of Viewpoint. “This award is particularly exciting because it provides support for new ideas that expand the potential of our portfolio”.

“We have some exciting new ideas about image-guided therapy that this funding will allow us to explore in detail,” says Michael Schultz, PhD, CSO of Viewpoint (also Associate Professor in the Departments of Radiology, Radiation Oncology, and Chemistry at University of Iowa). “We are excited about the momentum that we are experiencing and the potential that these new directions represent.”

Viewpoint’s products are currently under development and therefore not approved by the FDA.